Abstract
Brominated flame retardants are associated with increased toxicity and high concerns for environmental pollution. Therefore, organophosphate flame retardants (OPFRs) are considered safer alternatives and are widely used in building materials and electronics. This study aimed to determine whether organophosphate flame retardants are implicated in bladder cancer development and progression. Data of interactive genes associated with OPFRs was obtained from the CTD database (http://ctdbase.org/) in July 2021. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed that organophosphate flame retardants were closely linked to bladder cancer. Furthermore, the immune-related genes showed a strong correlation with bladder cancer. Further analysis revealed that the immune-related genes were associated with the prognosis, clinical characteristics, and response to immunotherapies in bladder cancer. In conclusion, OPFRs and their metabolites could promote the progression of bladder cancer by affecting the expression of immune genes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
